SHEFFIELD, England, March 21, 2007--The Medical House PLC (“TMH”), (AIM:MLH) the drug delivery and orthopaedic devices company, is pleased to announce that following on from the announcement made in December 2005, it has been commissioned by an undisclosed European Government Agency to enter into a second phase of development for a system based on TMH’s ASI disposable autoinjector technology for the emergency administration of specific pharmaceutical compounds.
